dendritic cell

And we provide the patient with natural killer cells, lymphokine activated killer cells, sometimes tumor infiltrating lymphocytes to help the patient fight their own tumors.

And all of this is orchestrated with dendritic cells.

Dendritic cells are the ones that present the anti to the immune system so that the immune system can attack a tumor.

And so we create this anti-tumor task force with tremendous results.

For instance, the five-year survival rate of Stage four breast cancer in America is about, with all of the conventional therapies, our five-year survival rate in stage four breast cancer with patients that already received chemotherapy, radiation therapy, surgery, hormone therapy before is fifth.

Who are the cutting edge researchers in this space that you follow?

Well, true cutting edge is CAR T cells.

And the beauty about CAR T cells is that, for instance, when you prepare dendritic cells, we obtain, they're converted from monocytes, okay? So let's say that we get 100 monocytes from our patient and we will expand them to millions, about 10 million, and convert them to dendritic cells.